劲方医药-B(02595):GFH375获得国内首个KRAS G12D抑制剂治疗非小细胞肺癌的突破性疗法认定
Last Update:
2 3 月, 2026
Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.